Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.38M | 3.84M | 6.39M | 7.37M | 6.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38M | 3.84M | 6.39M | 7.37M | 6.28M |
| Cost of Revenue | 43.02M | 48.86M | 55.81M | 61.39M | 63.22M |
| Gross Profit | -40.64M | -45.01M | -49.42M | -54.02M | -56.94M |
| SG&A Expenses | 35.02M | 36.51M | 36.69M | 39.25M | 40.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.05M | 85.37M | 92.50M | 100.64M | 103.60M |
| Operating Income | -75.67M | -81.53M | -86.11M | -93.27M | -97.32M |
| Income Before Tax | -105.81M | -112.77M | -116.62M | -88.31M | -91.26M |
| Income Tax Expenses | 839.00K | 732.00K | 637.00K | 104.00K | 95.00K |
| Earnings from Continuing Operations | -106.64 | -113.50 | -117.26 | -88.42 | -91.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.64M | -113.50M | -117.26M | -88.42M | -91.36M |
| EBIT | -75.67M | -81.53M | -86.11M | -93.27M | -97.32M |
| EBITDA | -73.09M | -78.09M | -81.83M | -88.38M | -92.75M |
| EPS Basic | -10.00 | -11.67 | -12.47 | -9.42 | -9.76 |
| Normalized Basic EPS | -3.91 | -4.88 | -5.38 | -5.80 | -6.01 |
| EPS Diluted | -10.00 | -11.67 | -12.47 | -9.42 | -9.76 |
| Normalized Diluted EPS | -3.91 | -4.88 | -5.38 | -5.80 | -6.01 |
| Average Basic Shares Outstanding | 48.02M | 39.80M | 37.58M | 37.53M | 37.45M |
| Average Diluted Shares Outstanding | 48.02M | 39.80M | 37.58M | 37.53M | 37.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |